Newark, New Castle, USA, April 20, 2023 (GLOBE NEWSWIRE) — According to the most recent study by Growth Plus Reports, the global Eosinophilia-Myalgia Syndrome Market is expected to register a revenue CAGR of 3.28% by 2031. The global market for eosinophilia-myalgia syndrome was analyzed, and it is expected to rise…Read More
Related Posts
Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit
MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,…
CHOP and Penn Medicine researchers develop in vivo RNAbased gene
Philadelphia, July 28, 2023 -- In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the…
Alector to Host MidYear Earnings Conference Call
SOUTH SAN FRANCISCO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced it will host a conference call and webcast…
